Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value: $2.28B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 8,494,151 | $427M | 18.7% | $12.22 | +343.9% | CLASS A ORD | 61559X104 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 6,893,235 | $142M | 6.3% | $10.42 | +137.5% | COM NEW | 30233G209 |
| ACLX | ARCELLX INC | 1,780,000 | $124M | 5.4% | $23.33 | +171.9% | COMMON STOCK | 03940C100 |
| — | ALPINE IMMUNE SCIENCES INC | 2,700,000 | $107M | 4.7% | $14.85 | — | COM | 02083G100 |
| BBIO | BRIDGEBIO PHARMA INC | 3,203,029 | $99.04M | 4.3% | $17.77 | +91.4% | COM | 10806X102 |
| PRAX | PRAXIS PRECISION MEDICINES I | 1,310,000 | $79.94M | 3.5% | $31.88 | +40.7% | COM NEW | 74006W207 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 2,025,000 | $79.46M | 3.5% | $24.66 | 0.0% | COM NEW | 21833P301 |
| TARS | TARSUS PHARMACEUTICALS INC | 2,139,102 | $77.76M | 3.4% | $21.36 | +37.6% | COM | 87650L103 |
| — | LONGBOARD PHARMACEUTICALS IN | 3,353,141 | $72.43M | 3.2% | $16.70 | — | COM | 54300N103 |
| EWTX | EDGEWISE THERAPEUTICS INC | 3,006,534 | $54.84M | 2.4% | $24.12 | -34.1% | COM | 28036F105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,150,000 | $53.83M | 2.4% | $21.03 | +86.1% | COM | 22663K107 |
| BMEA | BIOMEA FUSION INC | 3,570,872 | $53.38M | 2.3% | $17.07 | -3.5% | COM | 09077A106 |
| KRRO | KORRO BIO INC | 529,170 | $47.63M | 2.1% | $32.95 | +65.6% | COM | 500946108 |
| PCVX | VAXCYTE INC | 685,000 | $46.79M | 2.1% | $44.76 | +54.7% | COM | 92243G108 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 6,616,667 | $42.21M | 1.9% | $7.91 | — | SPON ADS | 05280R100 |
| PHVS | PHARVARIS N V | 1,711,460 | $39.55M | 1.7% | $21.48 | +23.6% | COM | N69605108 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 1,500,000 | $35.48M | 1.6% | $20.30 | 0.0% | ORDINARY SHARES | N62509109 |
| CGON | CG ONCOLOGY INC | 800,000 | $35.12M | 1.5% | $40.84 | 0.0% | COM | 156944100 |
| ALXO | ALX ONCOLOGY HLDGS INC | 3,142,079 | $35.03M | 1.5% | $15.94 | -11.9% | COM | 00166B105 |
| BHVN | BIOHAVEN LTD | 616,963 | $33.74M | 1.5% | $44.81 | +10.5% | COM | G1110E107 |
| — | MERUS N V | 715,000 | $32.2M | 1.4% | $45.03 | — | COM | N5749R100 |
| — | AEROVATE THERAPEUTICS INC | 1,069,796 | $31.63M | 1.4% | $20.58 | — | COM | 008064107 |
| ABVX | ABIVAX SA | 2,130,000 | $30.46M | 1.3% | $10.70 | — | SPONSORED ADS | 00370M103 |
| BBOT | HELIX ACQUISITION CORP II | 2,909,000 | $30.25M | 1.3% | $10.35 | 0.0% | CL A ORD SHS | G4444H101 |
| — | MARINUS PHARMACEUTICALS INC | 3,250,000 | $29.38M | 1.3% | $8.59 | — | COM NEW | 56854Q200 |
| — | TOURMALINE BIO INC | 1,250,000 | $28.63M | 1.3% | $22.90 | — | COM | 89157D105 |
| JANX | JANUX THERAPEUTICS INC | 750,000 | $28.24M | 1.2% | $21.78 | 0.0% | COM | 47103J105 |
| NGNE | NEUROGENE INC | 538,714 | $27.42M | 1.2% | $14.32 | +133.2% | COM | 64135M105 |
| — | CARGO THERAPEUTICS INC | 1,182,563 | $26.39M | 1.2% | $23.15 | — | COM | 14179K101 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 550,000 | $23.83M | 1.0% | $19.33 | +126.4% | COM | 76243J105 |
| APLS | APELLIS PHARMACEUTICALS INC | 400,000 | $23.51M | 1.0% | $42.18 | +51.1% | COM | 03753U106 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 2,125,000 | $21.06M | 0.9% | $7.46 | 0.0% | COM | 03969K108 |
| IDYA | IDEAYA BIOSCIENCES INC | 450,000 | $19.75M | 0.9% | $16.14 | +166.3% | COM | 45166A102 |
| CABA | CABALETTA BIO INC | 1,100,000 | $18.77M | 0.8% | $21.46 | 0.0% | COM | 12674W109 |
| — | ASTRIA THERAPEUTICS INC | 1,300,000 | $18.3M | 0.8% | $14.07 | — | COM | 04635X102 |
| ENGN | ENGENE HOLDINGS INC | 1,000,000 | $16.95M | 0.7% | $12.24 | 0.0% | COM | 29286M105 |
| INSM | INSMED INC | 575,000 | $15.6M | 0.7% | $22.87 | +22.4% | COM PAR $.01 | 457669307 |
| VTYX | VENTYX BIOSCIENCES INC | 2,710,000 | $14.9M | 0.7% | $4.57 | 0.0% | COM | 92332V107 |
| NKTX | NKARTA INC | 1,350,000 | $14.59M | 0.6% | $10.40 | 0.0% | COM | 65487U108 |
| SLN | SILENCE THERAPEUTICS PLC | 625,000 | $13.5M | 0.6% | $21.60 | — | ADS | 82686Q101 |
| — | MERSANA THERAPEUTICS INC | 2,600,000 | $11.65M | 0.5% | $4.48 | — | COM | 59045L106 |
| CMPX | COMPASS THERAPEUTICS INC | 5,560,300 | $11.01M | 0.5% | $1.73 | 0.0% | COM | 20454B104 |
| KYTX | KYVERNA THERAPEUTICS INC | 440,000 | $10.93M | 0.5% | $27.84 | 0.0% | COM | 501976104 |
| BEAM | BEAM THERAPEUTICS INC | 300,000 | $9.912M | 0.4% | — | — | Put | 07373V105 |
| IMRX | IMMUNEERING CORP | 3,295,273 | $9.523M | 0.4% | $18.88 | -70.3% | CLASS A COM | 45254E107 |
| SYRE | SPYRE THERAPEUTICS INC | 250,000 | $9.482M | 0.4% | $13.78 | +110.3% | COM NEW | 00773J202 |
| AVBP | ARRIVENT BIOPHARMA INC | 515,000 | $9.198M | 0.4% | $20.17 | 0.0% | COM | 04272N102 |
| RCKT | ROCKET PHARMACEUTICALS INC | 300,000 | $8.082M | 0.4% | $16.47 | +72.4% | COM | 77313F106 |
| IRON | DISC MEDICINE INC | 125,000 | $7.782M | 0.3% | $35.48 | +82.7% | COM | 254604101 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 561,600 | $6.346M | 0.3% | $15.97 | — | SPONSORED ADS | 152309100 |
| GHRS | GH RESEARCH PLC | 593,043 | $6.322M | 0.3% | $20.43 | -61.1% | ORDINARY SHARES | G3855L106 |
| STOK | STOKE THERAPEUTICS INC | 427,163 | $5.767M | 0.3% | $26.85 | -77.4% | COM | 86150R107 |
| LNTH | LANTHEUS HLDGS INC | 75,000 | $4.668M | 0.2% | $67.75 | -13.1% | COM | 516544103 |
| — | VERVE THERAPEUTICS INC | 350,000 | $4.648M | 0.2% | $49.89 | — | COM | 92539P101 |
| — | RAPT THERAPEUTICS INC | 496,750 | $4.461M | 0.2% | $20.60 | — | COM | 75382E109 |
| VYNE | VYNE THERAPEUTICS INC | 1,394,336 | $4.281M | 0.2% | $3.12 | -30.9% | COM | 92941V308 |
| BCAB | BIOATLA INC | 1,170,870 | $4.028M | 0.2% | $19.72 | -87.4% | COM | 09077B104 |